Here’s whether 10x Genomics, Inc. Class A Common Stock (TXG) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+16.18% over 10 days); RSI 64 — healthy momentum range; strong 1-year return of +237.0%; 3-month momentum positive (+109.6%). Currently 6.5% off its 52-week high. Score: +7/7.
TXG is in a confirmed uptrend, trading above both its 50-day ($34.02) and 200-day ($22.47) moving averages. An RSI of 63.6 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +237.0% compares to +16.5% for SPY (beat the market by 220.5%).
$10,000 invested 1 year ago→ $33,700 today
vs. S&P 500 (SPY) — same period beat market by 220.5%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($22.47)
✓Above 50-day MA ($34.02)
✓RSI(14) neutral zone (30–70) — currently 63.6
✓Positive return (+237.0%)
✓Within 10% of period high (−6.5%)
Period Range $46.27
$11.16$49.50
RSI (14) 63.6
0 · OversoldOverbought · 100
Key Metrics
Price$46.27
Period Return+237.0%
Period High$49.50
Period Low$11.16
Drawdown−6.5%
MA-50$34.02
MA-200$22.47
RSI (14)63.6
Avg Volume (30d)3.3M
vs. SPYbeat by 220.5%
Return Rank#41 of 999
Trend Signals
Price is above the 200-day moving average ($22.47)